David Eveleth is the founder of Trefoil Therapeutics. Trefoil Therapeutics has raised $50M in total funding. Latest round: Series B.
David Eveleth, PhD, is the Founder and CEO of Trefoil Therapeutics, a clinical-stage biotechnology company focused on regenerative therapies for corneal diseases. He has led the company to raise over $50 million and advance its lead product, TTHX1114, through successful Phase 2 clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library